Loading clinical trials...
Loading clinical trials...
Placental miRNA (microRNA) Profile in Fetal Overgrowth Related to Maternal Obesity Study
The purpose of this study is to determine whether placental and umbilical cord blood miRNA expression is altered in women with obesity with macrosomic neonates to when compared to miRNA expression from control patients.
MicroRNA's are a class of non-coding RNA's that function as translational repressors and are thought to modulate tissue development, proliferation, differentiation and function. Differential expression of certain placental miRNA's has been associated with preeclampsia. The fetal origins of adult disease hypothesis suggests that risk factors from intrauterine environmental exposures affect the fetus' development during sensitive periods, and increases the risk of specific diseases in adult life. Our aim is to understand factors that predispose fetuses to fetal overgrowth in utero, especially in women with obesity. The objective of the study is to identify miRNA which are differentially expressed in the placenta and cord blood of pregnancies that are affected by fetal macrosomia to determine factors that may predispose fetuses to fetal overgrowth.
Age
18 - 45 years
Sex
FEMALE
Healthy Volunteers
No
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
January 1, 2013
Primary Completion Date
February 1, 2014
Completion Date
February 1, 2014
Last Updated
May 26, 2014
82
ACTUAL participants
Neonatal exposure to maternal obesity
BEHAVIORAL
Lead Sponsor
University of Pennsylvania
NCT01143454
NCT07472881
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions